Polyphenol Intake in Elderly Patients: A Novel Approach to Counteract Colorectal Cancer Risk?

Area of Science:

• Oncology
• Nutritional Science
• Geriatrics

Background:

• Colorectal cancer (CRC) is a significant health concern, particularly in individuals over 70.
• Therapeutic strategies for elderly CRC patients are complex, influenced by frailty, comorbidities, and chemotherapy tolerance.
• Adverse drug reactions in older adults can necessitate dose reductions, negatively impacting oncologic outcomes.

Purpose of the Study:

• To review the chemopreventive potential of polyphenols against colorectal cancer (CRC) in the elderly.
• To explore the molecular mechanisms underlying polyphenol activity in CRC chemoprevention.
• To assess the antitumor effects of polyphenols in the elderly population based on experimental data.

Main Methods:

• Comprehensive literature search of major scientific databases.
• Analysis of in vitro and in vivo experimental data on key polyphenols.
• Focus on molecular mechanisms and antitumor effects relevant to elderly CRC patients.

Main Results:

• Polyphenols demonstrate chemopreventive activity by modulating cell signaling pathways, inhibiting cancer development and progression in experimental studies.
• In vitro and in vivo data suggest potential antitumor effects of polyphenols in CRC.
• Clinical trial efficacy has not been confirmed, primarily due to issues with polyphenol bioavailability and achieving non-toxic, effective doses.

Conclusions:

• Polyphenols exhibit promising chemopreventive and antitumor properties against colorectal cancer through molecular pathway modulation.
• Further research is essential to enhance polyphenol bioavailability and reduce side effects.
• Optimizing polyphenol delivery and dosage is crucial for their potential integration into chemotherapeutic regimens for elderly CRC patients.